Find Reports

Select Report Type

Reimbursement Review

Displaying 1226 - 1250 of 1258

Please scroll or swipe to the right to view the full content.

Brand Name	Generic Name	Files	Therapeutic Area	Recommendation Type	Status	Submission Date	Project Number
Adderall XR	Mixed amphetamine salts	cdr_tracking_AdderallXR_Resubmission.pdf	Attention deficit hyperactivity disorder		Withdrawn	Dec 15, 2004	SR0027-000
Xolair	Omalizumab	cdr_tracking_Xolair.pdf	Asthma, severe persistent		Cancelled	Apr 18, 2005	SR0035-000
Cipralex	Escitalopram oxalate	cdr_tracking_Cipralex.pdf	Depression, Major Depressive Disorder (MDD)		Withdrawn	Aug 3, 2005	SR0039-000
Forteo	Teriparatide (rDNA origin) injection	cdr_tracking_Forteo_resubmission.pdf	Osteoporosis		Withdrawn	May 29, 2006	SR0065-000
Altace HCT	Ramipril/hydrochlorothiazide	cdr_tracking_AltaceHCT.pdf	Hypertension		Cancelled	Oct 26, 2006	SR0083-000
Zytram XL	Tramadol hydrochloride	cdr_tracking_ZytramXL.pdf	Pain, acute		Withdrawn	Nov 3, 2006	SR0086-000
Forteo	Teriparatide (rDNA origin) injection	cdr_tracking_Forteo_Resubmission_3.pdf	Osteoporosis		Withdrawn	Jun 12, 2009	SR0169-000
Pradaxa	Dabigatran etexilate	cdr_tracking_Pradax_pre-noc.pdf	Atrial fibrillation prevention of stroke and systemic embolism		Cancelled	May 31, 2010	SR0202-000
Brilinta	Ticagrelor	cdr_tracking_Brilinta_pre-noc.pdf	Acute Coronary Syndromes		Cancelled	Jun 8, 2010	SR0203-000
Twynsta	Telmisartan / Amlodipine	cdr_trracking_Twynsta_PreNOC.pdf	Hypertension		Cancelled	Jul 9, 2010	SR0207-000
BuTrans	Buprenorphine transdermal patch	cdr_tracking_BuTrans.pdf	Pain, persistent (moderate intensity)		Cancelled	Oct 15, 2010	SR0211-000
Targin	Oxycodone / naloxone	cdr_tracking_Targin.pdf	Pain, Moderate to severe and relief of opioid-induced constipation		Cancelled	Nov 30, 2010	SR0219-000
Onsolis	Fentanyl Citrate	cdr_tracking_Onsolis_1.pdf	Pain, breakthrough cancer pain		Withdrawn	May 10, 2011	SR0229-000
Kuvan	Sapropterin dihydrochloride	cdr_tracking_Kuvan_request-advice.pdf	Phenylketonuria	N/A	Complete	Jun 1, 2011	SF0236-000
Xarelto	Rivaroxaban	cdr_tracking_xarelto_request-advice.pdf	Venous thromboembolism, prevention	N/A	Complete	Jun 24, 2011	SF0239-000
Onglyza	Saxagliptin	cdr_tracking_Onglyza-Resub1.pdf	Diabetes mellitus, type 2		Withdrawn	May 28, 2012	SR0280-000
Avastin	Bevacizumab				Withdrawn	Dec 16, 2016	PC0100-000
Victoza	Liraglutide	cdr_SR0505_Victoza_Resubmission.pdf	Diabetes Mellitus, Type 2		Withdrawn	Oct 20, 2016	SR0505-000
Onivyde	Nanoliposomal Irinotecan				Cancelled		PC0096-000
Kisqali	ribociclib	Patient and Clinician Group input	Adjuvant treatment of HR-positive, HER2-negative early breast cancer		Suspended	Dec 19, 2024	PC0395-000
Enhertu	trastuzumab deruxtecan	Patient and Clinician Group Input	Gastric or gastroesophageal junction (GEJ) adenocarcinoma		Active	Sep 16, 2024	PC0367-000
Dupixent	dupilumab	Patient and Clinician Group Input	Prurigo nodularis (PN)		Active	Dec 20, 2024	SR0876-000
Winlevi	clascoterone	Draft Recommendation Patient and Clinician Group input	Acne vulgaris		Active	Aug 6, 2024	SR0863-000
TBC	nemolizumab		Prurigo nodularis (PN)		Active	Jan 7, 2025	SR0861-000
Columvi	glofitamab		Relapsed or refractory diffuse large B-cell lymphoma		Pending		PC0406-000

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 589 of 589

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 111 of 111

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 40 of 40

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1226 - 1250 of 2093

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
Harmonization of Public Coverage Policies for Biologic Drugs in the Treatment of Rheumatoid Arthritis	Optimal Use 360 Report Utilization Review Budget Impact Analysis	Apr 17, 2020	Health Technology Review		Complete	HD0001-000
Skin Preparation for Injections: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines	RC1218 Skin Prep Injection Final corrected.pdf	Apr 16, 2020	Health Technology Review	Summary with Critical Appraisal	Completed	RC1218-000
Exercise for the Treatment of Ankle Sprain: A Review of Clinical Effectiveness and Guidelines	RC1261 - Exercise ankle sprain Final.pdf	Apr 13, 2020	Health Technology Review	Summary with Critical Appraisal	Completed	RC1261-000
vortioxetine hydrobromide	SR0611 Trintellix - Final CDEC Recommendation February 14, 2020_For posting.pdf sr0611-trintellix-clinical-review-report.pdf sr0611-trintellix-pharmacoeconomic-review-report.pdf SR0611-trintellix-pi-submission-redacted.pdf	Apr 9, 2020	Reimbursement Review		Complete	SR0611-000
Trifluridine-Tipiracil (Lonsurf) for Gastric Cancer — Details	Trifluridine-TipiracilLonsurf_GastricCancer10197ProvFunding.pdf 10197TrifluridineTipiracilGC_fnRec_EarlyConv_ApprovedbypERCChair_Post024Mar2020_final.pdf 10197TrifluridineTipiracilGC_inEGR_NOREDACT-ABBREV_EC24Mar2020_final.pdf 10197TrifluridineTipiracilGC_fnCGR_NOREDACT_EC24Mar2020_final.pdf 10197TrifluridineTipiracilGC_inRec_2020-03-03_ApprovedbyChair_Post_05Mar2020_final.pdf 10197TrifluridineTipiracilGC_PAGFeedbackSummary_EC24Mar2020_final.pdf 10197TrifluridineTipiracilGC_SponsorFeedback_EC24Mar2020_final.pdf 10197TrifluridineTipiracilGC_ClinicianFeedback_EC24Mar2020_final.pdf 10197TrifluridineTipiracilGC_MGF_COI_EC24Mar2020final_Redacted.pdf 10197TrifluridineTipiracilGC_Combined_COIs_EC24Mar2020_Redacted.pdf	Apr 8, 2020	Reimbursement Review		Complete	PC0197-000
Bacille Calmette-Guérin Vaccination: A Review of Clinical Effectiveness and Guidelines	RC1264 BCG Vaccination Final.pdf	Apr 6, 2020	Health Technology Review	Summary with Critical Appraisal	Completed	RC1264-000
Smartphone-Connected Ultrasound Devices		Apr 3, 2020	Horizon Scan	Emerging Health Technologies	Completed	Eh0079-000
upadacitinib	SR0614 Rinvoq - CDEC Final Recommendation February 6, 2020_for posting.pdf sr0614-rinvoq-clinical-review-report.pdf sr0614-rinvoq-pharmacoeconomic-review-report.pdf SR0614 Upadacitinib - Group Patient Input September 12, 2019.pdf	Apr 1, 2020	Reimbursement Review		Complete	SR0614-000
Masks for Prevention of Influenza Transmission in Acute and Long-Term Care Settings: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines	RC1255 Influenza Masks Final.pdf	Mar 31, 2020	Health Technology Review	Summary with Critical Appraisal	Completed	RC1255-000
Intravitreal Dexamethasone Implants for Non-infectious Uveitis: A Review of Clinical Effectiveness, Cost-effectiveness, and Guidelines	RC1257-000 Ozurdex Uveitis Final.pdf	Mar 31, 2020	Health Technology Review	Summary with Critical Appraisal	Completed	RC1257-000
Body Weight Modification Interventions for Chronic Non-Cancer Pain: A Review of Clinical Effectiveness	RC1258 Weight change pain Final.pdf	Mar 31, 2020	Health Technology Review	Summary with Critical Appraisal	Completed	RC1258-000
Serial X-Ray Radiography for the Diagnosis of Osteomyelitis: A Review of Diagnostic Accuracy, Clinical Utility, Cost-Effectiveness, and Guidelines	RC1256 Serial Radiography Osteomyelitis Final.pdf	Mar 23, 2020	Health Technology Review	Summary with Critical Appraisal	Completed	RC1256-000
Assessment of Dehydration and Oral Rehydration Therapy for Pediatric Patients with Dehydration: A Review of Clinical Effectiveness, Clinical Utility, and Guidelines	RC1240 ORT diagnosis treatment Final.pdf	Mar 23, 2020	Health Technology Review	Summary with Critical Appraisal	Completed	RC1240-000
Propranolol for Post-Traumatic Stress Disorder: A Review of Clinical Effectiveness	RC1254 Propranolol PTSD Final.pdf	Mar 23, 2020	Health Technology Review	Summary with Critical Appraisal	Completed	RC1254-000
Daratumumab (Darzalex) for Multiple Myeloma	10189DaratumumabNDMM_fnRec_2020-03-03_ApprovedbyChair_Post_05Mar2020_final.pdf 10189DaratumumabNDMM_fnEGR_NOREDACTABBREV_Post05Mar2020_final.pdf 10189DaratumumabNDMM_fnCGR_Post05Mar2020_REDACT_Final.pdf 10189DaratumumabNDMM_inRec_2020_01-03_ApprovedbyChair_Post_03Jan2019_final.pdf 10189DaratumumabNDMM_PAGFeedbackSummary_Post05Mar2020_final.pdf 10189DaratumumabNDMM_SponsorFeedback_Post_05Mar2020_final.pdf 10189DaratumumabNDMM_ClinicianFeedback_CCO_Post05Mar2020_final.pdf 10189DaratumumabNDMM_PatientCOI_Post05Mar2020_final.pdf 10189DaratumumabNDMM_Combined_COI_Post_05Mar2020_final_Redacted.pdf	Mar 20, 2020	Reimbursement Review		Complete	PC0189-000
Early Identification of Ischemic Stroke		Mar 19, 2020	Horizon Scan	Emerging Health Technologies	Completed	EH0080-000
The Use of Real-World Evidence for Medical Device Assessment: An Environmental Scan		Mar 19, 2020	Health Technology Review			ES0344-000
Endobronchial Valves for the Treatment of Severe Emphysema		Mar 19, 2020	Horizon Scan	Emerging Health Technologies	Completed	EH0083-000
Experiences with and Expectations of Robotic Surgical Systems: A Rapid Qualitative Review	RC1251 RSS for Gyno Uro Surgery Final.pdf	Mar 19, 2020	Health Technology Review	Summary with Critical Appraisal	Completed	RC1251-000
Small Molecule Calcitonin Gene-Related Peptide Receptor Antagonists for the Acute Treatment of Migraine		Mar 19, 2020	Horizon Scan	Emerging Health Technologies	Completed	EH0081-000
The Use of Real-World Evidence for Medical Device Assessment ─ An Environmental Scan		Mar 19, 2020	Health Technology Review			ES0344-000
Identification of Tuberculosis: A Review of the Guidelines	RC1236 TB identification Final.pdf	Mar 18, 2020	Health Technology Review	Summary with Critical Appraisal	Completed	RC1236-000
Drug-Resistant Tuberculosis: A Review of the Guidelines	RC1239 DR-TB guidelines Final.pdf	Mar 18, 2020	Health Technology Review	Summary with Critical Appraisal	Completed	RC1239-000
Treatment of Tuberculosis: A Review of Guidelines	RC1237 TB treatment guidelines Final.pdf	Mar 18, 2020	Health Technology Review	Summary with Critical Appraisal	Completed	RC1237-000
Tuberculosis in People with Compromised Immunity: A Review of Guidelines	RC1238 TB immunocompromised Final.pdf	Mar 18, 2020	Health Technology Review	Summary with Critical Appraisal	Completed	RC1238-000